COVID-19 vaccine associated transverse myelitis-Evusheld as an option when vaccination is not recommended due to severe adverse events

Individuals who experience severe COVID-19-vaccine-related adverse reactions such as transverse myelitis may be precluded from receiving further vaccination to protect from SARS-CoV-2 infection. Although the mechanism of autoimmune spinal cord inflammation resulting in transverse myelitis is unclear...

Descripción completa

Detalles Bibliográficos
Autor principal: Fitzsimmons, William E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Coronavirus – Letters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302530/
https://www.ncbi.nlm.nih.gov/pubmed/35511579
http://dx.doi.org/10.1080/21645515.2022.2068338

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302530/
https://www.ncbi.nlm.nih.gov/pubmed/35511579
http://dx.doi.org/10.1080/21645515.2022.2068338

Ejemplares similares